BSE Live
Dec 12, 16:01Prev. Close
125.40
Open Price
129.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 12, 15:58Prev. Close
126.29
Open Price
124.20
Bid Price (Qty.)
127.10 (248)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Indo US Bio-Tech (in Rs. Cr.) | Mar 15 | Mar 14 | Mar 13 | |
| 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.25 | 0.11 | 0.21 | |
| Net CashFlow From Operating Activities | 0.14 | 0.46 | -0.63 | |
| Net Cash Used In Investing Activities | -0.17 | -0.21 | -0.36 | |
| Net Cash Used From Financing Activities | 0.03 | -0.25 | 0.99 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.00 | 0.00 | 0.00 | |
| Cash And Cash Equivalents Begin of Year | 0.00 | 0.00 | 0.00 | |
| Cash And Cash Equivalents End Of Year | 0.01 | 0.00 | 0.00 |
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
19.11.2025
Indo US Bio-Tec Standalone September 2025 Net Sales at Rs 30.85 crore, up 39.12% Y-o-Y
08.09.2025
Indo US Bio-Tec Standalone June 2025 Net Sales at Rs 30.77 crore, up 24.48% Y-o-Y
27.05.2025
Indo US Bio-Tec Standalone March 2025 Net Sales at Rs 33.38 crore, up 111.75% Y-o-Y
17.02.2025
Indo US Bio-Tec Standalone December 2024 Net Sales at Rs 23.56 crore, up 6.56% Y-o-Y
15.02.2017
15.02.2017
14.02.2017
13.02.2017